WEIKANG BIO-TECHNOLOGY GROUP CO., INC. Selling Expense
WEIKANG BIO-TECHNOLOGY GROUP CO., INC. reported Selling Expense of $608.23 thousand for the 3-month period ending 2012-09-30, per its 10-Q/A filed 2012-12-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2012-12-11
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. selling expense for the quarter ending 2012-09-30 was $608.23K, a 25.44% decline year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. selling expense for the quarter ending 2012-06-30 was $604.70K, a 63.25% decline year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. selling expense for the quarter ending 2012-03-31 was $659.17K, a 30.30% decline year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. selling expense for the quarter ending 2011-12-31 was $1.33M, a 42.57% increase year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. selling expense for fiscal 2011 was $4.73M, a 41.42% increase from fiscal 2010.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. selling expense for fiscal 2010 was $3.35M.
| Period end | Selling Expense 3 month | Selling Expense 6 month | Selling Expense 9 month | Selling Expense 12 month |
|---|---|---|---|---|
| 2012-09-30 | $608.23K 10-Q/A · filed 2012-12-11 | $1.21M derived: sum of 2 quarters · filed 2012-12-11 | $1.87M 10-Q/A · filed 2012-12-11 | $3.20M derived: sum of 4 quarters · filed 2012-12-11 |
| 2012-06-30 | $604.70K 10-Q/A · filed 2012-08-30 | $1.26M 10-Q/A · filed 2012-08-30 | $2.59M derived: sum of 3 quarters · filed 2012-08-30 | $3.41M derived: sum of 4 quarters · filed 2012-12-11 |
| 2012-03-31 | $659.17K 10-Q · filed 2012-05-15 | $1.99M derived: sum of 2 quarters · filed 2012-05-15 | $2.80M derived: sum of 3 quarters · filed 2012-12-11 | $4.45M derived: sum of 4 quarters · filed 2012-12-11 |
| 2011-12-31 | $1.33M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30 | $2.14M derived: sum of 2 quarters · filed 2012-12-11 | $3.79M derived: sum of 3 quarters · filed 2012-12-11 | $4.73M 10-K · filed 2012-03-30 |
| 2011-09-30 | $815.77K 10-Q/A · filed 2012-12-11 | $2.46M derived: sum of 2 quarters · filed 2012-12-11 | $3.41M 10-Q/A · filed 2012-12-11 | $4.34M derived: sum of 4 quarters · filed 2012-12-11 |
| 2011-06-30 | $1.65M 10-Q/A · filed 2012-08-30 | $2.59M 10-Q/A · filed 2012-08-30 | $3.52M derived: sum of 3 quarters · filed 2012-08-30 | $4.14M derived: sum of 4 quarters · filed 2012-08-30 |
| 2011-03-31 | $945.72K 10-Q · filed 2012-05-15 | $1.88M derived: sum of 2 quarters · filed 2012-05-15 | $2.50M derived: sum of 3 quarters · filed 2012-05-15 | $3.60M derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | $931.31K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $1.55M derived: sum of 2 quarters · filed 2012-03-30 | $2.66M derived: sum of 3 quarters · filed 2012-03-30 | $3.35M 10-K · filed 2012-03-30 |
| 2010-09-30 | $622.34K 10-Q · filed 2011-11-21 | $1.73M derived: sum of 2 quarters · filed 2011-11-21 | $2.42M 10-Q · filed 2011-11-21 | |
| 2010-06-30 | $1.10M 10-Q/A · filed 2011-09-01 | $1.79M 10-Q/A · filed 2011-09-01 |